Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

395
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
395
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.1K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.1K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

3.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
3.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

89
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
89
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

1.4K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.4K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

947
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
947

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[EUROPREV Forum Madrid 2026: «Towards a safe, effective and person-centered prevention»].

Atencion primaria·2026
Same author

Integrating preconception carrier screening into public health: lessons learned from a pilot implementation study.

Journal of assisted reproduction and genetics·2026
Same author

Vascular age: a tool to facilitate communication with patients about cardiovascular risk.

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis·2026
Same author

Standardization of A Method for the Detection of the Genus Prorocentrum, A Dinoflagellate Present in Harmful Algae Blooms (habs) in San Jorge Antofagasta Bay by Digital Droplet Pcr (ddPCR).

Marine biotechnology (New York, N.Y.)·2026
Same author

Assessing the impact of socioeconomic determinants and management models on primary health care in Catalonia.

Atencion primaria·2026
Same author

Distribution of Parasitic Nematodes Associated with Papaya in Major Production Zones of Burkina Faso.

Journal of nematology·2025

Related Experiment Video

Updated: Nov 5, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.3K

Epidemiology of hypertriglyceridaemia.

Carlos Brotons1, Irene Moral1, Jara González1

  • 1EAP Sardenya, Instituto de Investigaciones Biomédicas Sant Pau, Barcelona, España.

Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis
|May 19, 2021
PubMed
Summary
This summary is machine-generated.

High triglyceride levels increase cardiovascular disease risk. Lowering triglycerides shows efficacy in reducing cardiovascular events, supported by recent scientific evidence.

Keywords:
EpidemiologyEpidemiologíaTriglicéridosTriglycerides

More Related Videos

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.9K
The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion
06:14

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion

Published on: November 30, 2022

3.0K

Related Experiment Videos

Last Updated: Nov 5, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.3K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.9K
The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion
06:14

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion

Published on: November 30, 2022

3.0K

Area of Science:

  • Cardiology
  • Biochemistry
  • Public Health

Background:

  • Hypertriglyceridemia is a prevalent condition with significant health implications.
  • Elevated triglyceride levels are increasingly recognized as a risk factor for cardiovascular diseases (CVD).

Purpose of the Study:

  • To elucidate the relationship between triglyceride levels and cardiovascular disease risk.
  • To review the prevalence of hypertriglyceridemia and its association with CVD.
  • To summarize current evidence on the efficacy of triglyceride-lowering interventions for CVD risk reduction.

Main Methods:

  • Systematic review of national and international reports on hypertriglyceridemia prevalence.
  • Analysis of cohort studies examining the link between hypertriglyceridemia and CVD.
  • Evaluation of recent clinical trials, meta-analyses, and systematic reviews on triglyceride-lowering therapies.

Main Results:

  • Prevalence data on hypertriglyceridemia from diverse populations.
  • Established association between elevated triglycerides and increased CVD risk.
  • Evidence supporting the cardiovascular benefits of reducing triglyceride levels.

Conclusions:

  • Hypertriglyceridemia is a significant risk factor for cardiovascular diseases.
  • Lowering triglyceride levels is a viable strategy for cardiovascular risk reduction.
  • Further research and clinical application of triglyceride management are warranted.